Skip to main content
. 2022 May 11;13:824279. doi: 10.3389/fendo.2022.824279

Table 1.

Baseline and follow-up characteristics by incidence of DKD.

Non-DKD DKD p
Baseline
N (805) 609 196
Male [% (n)] 55.8 (340) 60.7 (119) 0.23
Age (years) 51.6 (10.0) 53.8 (9.7) 0.005
Duration (years) 6.7 (6.0) 9.4 (6.1) <0.001
BMI (kg/m2) 25.5 (25.2, 25.8) 25.9 (25.3, 26.4) 0.24
SBP (mmHg) 127.6 (126.3, 129.0) 129.6 (127.2, 132.0) 0.167
DBP (mmHg) 81.6 (80.7, 82.5) 83.2 (81.6, 84.8) 0.101
Family history [Yes, % (n)] 41.4 (252) 40.3 (79) 0.791
Smoker [Yes, % (n)] 17.4 (106) 28.1 (55) 0.001
Drinker [Yes, % (n)] 11.0 (67) 13.3 (26) 0.389
HBP [Yes, % n)] 36.5 (222) 41.3 (81) 0.979
CHD [Yes, % (n)] 11.3 (69) 15.8 (31) 0.995
INFAR [Yes, % (n)] 4.6 (28) 4.6 (9) 0.674
UACR (mg/g) 8.7 (8.1, 9.2) 13.6 (12.6, 14.6) <0.001
HbA1c (%) 8.1 (7.9, 8.2) 9.1 (8.8, 9.4) <0.001
FPG (mmol/L) 8.8 (8.5, 9.0) 10.0 (9.6, 10.4) <0.001
TC (mmol/L) 4.76 (4.69, 4.84) 4.94 (4.80, 5.08) 0.037
TG (mmol/L) 2.53 (2.28, 2.77) 3.21 (2.78, 3.63) 0.007
HDL (mmol/L) 1.07 (1.04, 1.09) 1.04 (1.00, 1.08) 0.281
LDL (mmol/L) 2.95 (2.88, 3.02) 2.95 (2.83, 3.07) 0.981
Urea (mmol/L) 5.3 (5.1, 5.4) 5.7 (5.5, 5.9) 0.001
UA (μmol/L) 304.4 (298.1, 310.8) 323.4 (311.8, 336.0) 0.005
Scr (μmol/L) 60.7 (59.6, 61.7) 62.7 (60.8, 64.5) 0.078
CysC (mg/L) 0.90 (0.89, 0.91) 0.94 (0.92, 0.96) <0.001
eGFR (ml/min per 1.73 m2) 105.3 (104.6, 106.0) 104.2 (102.9, 105.4) 0.135
Alb (g/L) 42.7 (42.5, 43.0) 43.6 (43.1, 44.0) 0.004
AST (U/L) 20.0 (18.4, 21.5) 23.3 (20.6, 26.1) 0.04
ALT (U/L) 25.5 (24.2, 26.9) 27.1 (24.7, 29.5) 0.267
Follow-up
Follow-up time (years) 5.1 (1.4) 4.2 (1.8) <0.001
Age (years) 56.8 (9.7) 57.2 (10.9) 0.200
Duration (years) 11.8 (6.1) 13.5 (6.3) 0.001
BMI (kg/m2) 24.7 (24.4, 25.0) 26.6 (26.0, 27.2) <0.001
SBP (mmHg) 131.8 (130.0, 133.6) 133.7 (130.3, 137.0) 0.336
DBP (mmHg) 77.9 (76.9, 79.0) 82.5 (80.5, 84.4) <0.001
UACR (mg/g) 10.5 (8.5, 12.4) 51.9 (48.5, 55.3) <0.001
HbA1c (%) 7.8 (7.7, 8.0) 8.5 (8.2, 8.7) <0.001
FPG (mmol/L) 8.0 (7.7, 8.2) 9.3 (8.8, 9.8) <0.001
TC (mmol/L) 4.60 (4.51, 4.68) 4.65 (4.51, 4.80) 0.507
TG (mmol/L) 2.13 (1.98, 2.28) 2.38 (2.11, 2.65) 0.117
HDL (mmol/L) 1.10 (1.07, 1.12) 1.11 (1.07, 1.16) 0.533
LDL (mmol/L) 2.77 (2.71, 2.83) 2.77 (2.66, 2.88) 0.0945
Urea (mmol/L) 5.18 (5.07, 5.29) 5.66 (5.47, 5.85) <0.001
UA (μmol/L) 320.0 (312.7, 327.2) 350.1 (337.0, 363.3) <0.001
Scr (μmol/L) 61.7 (60.6, 62.9) 64.5 (62.4, 66.6) 0.026
CysC (mg/L) 0.90 (0.89, 0.91) 0.95 (0.93, 0.97) <0.001
eGFR (ml/min per 1.73 m2) 100.7 (99.7, 101.7) 99.2 (97.5, 101.0) 0.040
Alb (g/L) 41.6 (41.4, 41.9) 43.4 (42.9, 43.9) <0.001
AST (U/L) 19.7 (19.1, 20.4) 19.5 (18.3, 20.6) 0.709
ALT (U/L) 24.0 (22.8, 25.2) 22.5 (20.4, 24.6) 0.235

Variables are presented as means (SD), n (%), or means (95% confidence interval) (after covariate analysis).

DKD, diabetic kidney disease; Non-DKD, non-diabetic kidney disease; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HBP, high blood pressure; CHD, coronary heart disease; INFAR, cerebral infarction; UACR, urine albumin/creatinine ratio; HbA1c, glycosylated hemoglobin A-1c; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein; Scr, serum creatinine; UA, uric acid; Cysc, cystatin C; eGFR, estimated glomerular filtration rate; Alb, albumin; AST, aspartate transaminase; ALT, alanine aminotransferase.

eGFR was calculated as the formula for CKD-EPI 2009.